Characterization of Lidocaine-Specific T Cells

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1139-1148

  Zanni, Martin P ^a   Mauri Hellweg, Daniela ^a   Brander, Christian ^a   Wendland, Thomas ^a   Schnyder, Benno ^a   Frei, Elisabeth ^a   Von Greyerz, Salome ^a   Bircher, Andreas ^b   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Allergologische Poliklinik   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 5; LIDOCAINE; LYMPHOCYTE ANTIGEN RECEPTOR; MEPIVACAINE;

ADULT; ARTICLE; BIOSYNTHESIS; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL CULTURE; CHEMISTRY; CONTACT DERMATITIS; CROSS REACTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; T LYMPHOCYTE SUBPOPULATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONE CELLS; CROSS REACTIONS; DERMATITIS, CONTACT; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LIDOCAINE; LYMPHOCYTE ACTIVATION; MALE; MEPIVACAINE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 0031066617     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. De Weck, A. L., and H. Birudspeard. 1983. Allergic reactions to drugs. Springer Verlag, Berlin, Germany.
2. De Week, A. L. 1986. Drugs as allergens. J. Allergy Clin. Immunol. 78:1047.
3. Pichler, W. J. 1989. T cell reactivity to drugs: progress in allergy and clinical immunology. In Proceedings of the 13th International Congress of Allergy and Clinical Immunology. W. J. Pichler, B. M. Stadler, C. Dahinden, A. R. Pécoud, P. C. Frei, C. Schneider, and A. L. de Weck, eds. Hogrefe & Huber Publishers. Lewiston, NY, pp. 442-444.
4. Weltzien, H. U., C. Moulon, S. Martin, E. Padovan, U. Hartmann, and J. Kohler. 1996. T cell immune responses to haptens: structural models for allergic and autoimmune reactions. Toxicology 107:141.
5. Weiss, M. E., and N. F. Adkinson. 1988. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin. Allergy 18:515.
6. Parker, C. W. 1982. Allergic reactions in man. Pharmacol. Rev. 34:85.
7. Gell, P. G. H., and R. R. A. Coombs, 1963. Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical Aspects of Immunology, P. G. H. Gell, R. R. A. Coombs, eds. Blackwell Scientific Publications, Oxford, U.K., pp. 317-337.
8. Martin, S., and H. U. Weltzien. 1994. T cell recognition of haptens, a molecular view. Int. Arch. Allergy Appl. Immunol. 104:10.
9. Park, B. K., J. W. Coleman, and N. R. Kitteringham. 1987. Drug disposition and drug hypersensitivity. Biochem. Pharmacol. 36:581.
10. Schneider, C. H., and A. L. de Weck. 1966. Chemische aspekte der penicillin-allergie: die direkte penicilloylierung von ε-aminogruppen durch penicilline bei pH 7.4. Helv. Chem. Acta 49:1693.
11. Bell, S. J. D., and W. J. Pichler. 1989. Penicillin-allergic patients react to penicillin-modified "self." Allergy 44:199.
12. + T cells. J. Immunol. 154:1232.
13. Brander C., D. Mauri-Hellweg, F. Bettens, H. Rolli, M. Goldman, and W. J. Pichler. 1995. Heterogeneous T cell responses to β-lactam-modified self structures are observed in penicillin allergic individuals. J. Immunol. 155:2670.
14. Zakrzewska, J. M., and L. Ivanyi. 1988. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxacarbamazepine in the diagnosis of drug induced hypersensitivity. J. Allergy Clin. Immunol. 82:110.
15. Rieder, M. J., J. Uetrecht, N. H. Shear, M. Cannon, M. Miller, and S. P. Spielberg. 1989. Diagnosis of sulfonamide hypersensitivity reactions by invitro "rechallange" with hydroxylamine metabolites. Ann. Intern. Med. 110:286.
16. Lecoeur, S., E. Bonierbale, D. Challine, J. C. Gautier, P. Valadon, P. M. Dansette, R. Catinot, F. Ballet, D. Mansuy, and P. H. Beaune. 1994. Specificity of in vitro covalent binding of tienelic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7:434.
17. + T cells in individuals allergic to sulfamethoxazole, phenytoin, and carbamazepine. J. Immunol. 155:462.
18. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144:4121.
19. Hauser, C. 1990. Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J. Invest. Dermatol. 95:436.
20. Hauser, C., and S. Katz. 1988. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc. Natl. Acad. Sci. USA 85:5625.
21. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:673.
22. Wei, L. K., M. Müller, J. H. Saurat, and C. Hauser. 1993. Lymphokine profiles in contact sensitivity induced by dinitrofluorobenzene and tolerance induced by dinitrothiocyanobenzene. Arch. Dermatol. Res. 284:427.
23. Romagnoli, P., A. M. Labhardt, and F. Sinigaglia. 1991. Selective interaction of Ni with an MHC-bound peptide. EMBO J. 10:1303.
24. Sinigaglia, F., D. Scheidegger, G. Garotta, R. Scheper, M. Pletscher, and A. Lanzavecchia. 1985. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J. Immunol. 135:3929.
25. + lymphocyte clones from nickel contact allergic and non-allergic individuals. J. Invest. Dermatol. 98:59.
26. Kalish, R. S., J. A. Wood, and A. LaPorte. 1994. Processing of urishol (poison ivy) by endogenous and exogenous pathways for presentation to T cells in vitro. J. Clin. Invest. 93:2039.
27. Bircher, A. J., S. Langauer, C. Surber, and T. Rufli. 1996. Delayed type hypersensitivity to subcutaneous lidocaine with tolerance of articaine: confirmation by in vivo and in vitro tests. Contact Dermatitis 34:387.
28. Hahn, C., S. Roseler, R. Fritzsche, R. Schneider, and H. F. Merk. 1993. Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28:81.
29. Wyss-Coray, T., D. Mauri-Hellweg, K. Baumann, F. Bettens, R. Grunow, and W. J. Pichler. 1993. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23:2175.
30. Sottini, A., L. Imberti, R. Gorla, R. Cattaneo, and D. Primi. 1991. Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis. Eur. J. Immunol. 21:461.
31. Mauri-Hellweg, D., M. P. Zanni, E. Frei, F. Bettens, C. Brander, and W. J. Pichler. 1996. Cross-reactivity of T cell lines and clones to β-lactam antibiotics. J. Immunol. 157:1071.
32. Gallati, H. 1982. Interferon: Wesentliche vereinfachte, enzymimmunologische bestimmung mit zwei monoklonalen antikörpern. J. Clin. Chem. Clin. Biochem. 20:907.
33. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia. 1993. Expression of two T cell receptor α chains: dual receptor T cells. Science 262:422.
34. + T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes. Clin. Exp. Immunol. 105:18.
35. Moulon, C., J. Vollmer, and H. U. Weltzien. 1995. Characterisation of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur. J. Immunol. 25:3308.
36. Probst, P., D. Küntzlin, and B. Fleischer. 1995. Th2-type infiltrating T cells in nickel-induced contact dermatitis. Cell Immunol. 165:134.
37. Tsutsui, H., Y. Terano, C. Sakagami, I. Hasegawa, Y. Mizoguchi, and S. Morisawa. 1992. Drug-specific T cells derived from patients with drug-induced allergic hepatitis. J. Immunol. 149:706.
38. Ptak, W., M. Szczepanik, R. Ramabhadran, and P. W. Askenase. 1996. Immune or normal γδ T cells that assist αβ T cells in elicitation of contact sensitivity preferentially use Vγ5 and Vδ4 variable region gene segments. J. Immunol. 156:976.
39. + T cells by keratinocytes treated with contact sensitizers. J. Immunol. 155:2888.
40. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1994. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:998.
41. Tanaka, Y., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-petide antigens recognized by human γδ T cells. Nature 375:155.
42. Tanaka, Y., S. Sano, E. Nieves, G. de Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human γδ T cells. Proc. Natl. Acad. Sci. USA 91:8175.
43. Martin, S., H. Ruh, S. Hebbelmann, U. Pflugfelder, B. Rüde, and H. U. Weltzien. 1995. Carrier-reactive hapten-specific cytolytic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity. Eur. J. Immunol. 25:2788.
44. Kohler, J., S. Martin, U. Pflugfelder, H. Ruh, J. Vollmer, and H. U. Weltzien. 1995. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibitity complex-restricted T cells and inducers of contact sensitivity in mice: limited T cell receptor repertoire. Eur. J. Immunol. 25:92